chitosan has been researched along with Carditis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Ji, H; Jiang, D; Liu, L; Yin, L; Zhang, L; Zhao, Q | 1 |
Dong, C; Li, X; Wang, M; Xiong, S; Xu, W; Yue, Y | 1 |
Chai, D; Dong, C; Xiong, S; Xu, W; Yue, Y | 2 |
Dong, C; Fan, X; Xiong, S; Xu, W; Ye, T; Yue, Y | 1 |
Fan, X; Xiong, S; Yue, Y | 1 |
Hu, L; Jiang, Z; Xiong, S; Xu, W; Yue, Y | 1 |
Xiong, S; Xu, W; Yue, Y | 1 |
8 other study(ies) available for chitosan and Carditis
Article | Year |
---|---|
Chitoheptaose Promotes Heart Rehabilitation in a Rat Myocarditis Model by Improving Antioxidant, Anti-Inflammatory, and Antiapoptotic Properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Chitosan; Disease Models, Animal; Heart; Humans; Male; Myocarditis; Rats | 2020 |
Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Feces; HMGB1 Protein; Immunoglobulin A, Secretory; Male; Mice; Mice, Inbred BALB C; Myocarditis; Survival Analysis; T-Lymphocytes; Vaccination; Vaccines, DNA; Viral Vaccines | 2013 |
Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
Topics: Animals; Chitosan; Coxsackievirus Infections; DNA-Binding Proteins; Enterovirus B, Human; HeLa Cells; Humans; Immunization; Immunoglobulin A, Secretory; Male; Mice; Mice, Inbred BALB C; Myocarditis; Nasal Mucosa; Treatment Outcome; Vaccines, DNA | 2014 |
M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Viral; Chitosan; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Immunity, Mucosal; Immunoglobulin A, Secretory; Immunoglobulin G; Male; Mice, Inbred BALB C; Myocarditis; T-Lymphocytes; Vaccines, DNA; Viral Load; Viral Vaccines | 2014 |
AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
Topics: Administration, Intranasal; Animals; CD8-Positive T-Lymphocytes; Chitosan; Chronic Disease; Coxsackievirus Infections; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Intestinal Mucosa; Mice, Inbred BALB C; Myocarditis; Myocardium; Vaccination; Vaccines, DNA | 2015 |
Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
Topics: Adhesins, Escherichia coli; Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Antigen-Presenting Cells; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Fimbriae Proteins; Immunity, Mucosal; Immunoglobulin A, Secretory; Mice, Inbred BALB C; Myocarditis; Vaccines, DNA; Viral Vaccines | 2017 |
Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Topics: Administration, Intranasal; Animals; Antibodies, Viral; CD8-Positive T-Lymphocytes; Chitosan; Coxsackievirus Infections; Enterovirus B, Human; Immunity, Innate; Immunity, Mucosal; Immunization; Lymphokines; Male; Mice; Mice, Inbred BALB C; Myocarditis; Neutralization Tests; Sialoglycoproteins; Th1 Cells; Vaccines, DNA; Viral Load; Viral Vaccines | 2009 |
Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Antigens, Viral; Blotting, Western; Chitosan; Coxsackievirus Infections; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Immunity, Mucosal; Kaplan-Meier Estimate; Lymphokines; Male; Mice; Mice, Inbred BALB C; Myocarditis; Plasmids; Sialoglycoproteins; T-Lymphocytes; Vaccines, DNA | 2012 |